* = Trainee

In Press/2020

1. Visser*, K.F., Chapman*, H.C., Ruiz*, I., Strauss, G.P. (2020). A meta-analysis of self-reported anticipatory and consummatory pleasure in the schizophrenia-spectrum. Journal of Psychiatric Research, 121, 68-81. 

2. Chang WC, Westbrook A, Strauss GP, Chu AOK, Chong CSY, Siu CMW, Chan SKW, Lee EMH, Hui CLM, Suen YM, Lo TL, Chen EYH (in press).  Abnormal cognitive effort allocation and its association with amotivation in first episode psychosis. Psychological Medicine. 

3.  Ying-min Zou, Y., Ni, K., Wang, Y., Yu, E., Lui, S.S., Zhou, F., Yang, H., Cohen, A.S., Strauss, G.P., Cheung, E.F.C., Chan, R.C.K. (in press). Effort-Cost Computation in a Transdiagnostic Psychiatric Sample: Differences Among Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. PsyCh Journal

4. Dwyer, K., Andrea, A., Savage, C., Orth, R., Shan, L., Strauss, G.P., Adams, H.A., Kelly, D.L., Weiner, E., Gold, J.M., McMahon, R.P., Carpenter, W.T., Buchanan, R.W., Blanchard, J. (in press). A randomized clinical trial of oxytocin or galantamine in schizophrenia: Assessing the impact on behavioral, lexical, and self-report indicators of social affiliation. Schizophrenia Bulletin Open.

5. Eunju, J., Park, K., Lee, E., Strauss, G.P., Choi, K.H. (in press). Validation of the brief negative symptom scale in Korean samples with schizophrenia. Asia Pacific Psychiatry.

6. Strauss, G.P., Zamani-Esfahlani*, F., Sayama, H., Kirkpatrick, B., Opler, M., Saoud, J.B., Davidson, M., Luthringer, R. (in press). Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: Evidence from the roluperidone clinical trial. Schizophrenia Bulletin.

7. Strauss, G.P., Zamani-Esfahlani*, Granholm, E., Holden, J., F., Visser*, K.H., Bartolomeo, L.A.*. Sayama, H. (in press). Modeling anhedonia in schizophrenia: A stochastic dynamical systems approach. Schizophrenia Bulletin.

8. Bartolomeo*, L.A., Chapman*, H.C., Raugh*, I.M., Strauss, G.P. (in press). Delayed discounting in youth at clinical high-risk for psychosis and adults with schizophrenia. Psychological Medicine.  

9. Greene, H.H., Brown, J.M., Strauss, G.P. (in press). Shorter fixation durations for up-directed saccades during saccadic exploration: A meta-analysis. Journal of Eye Movement Research.

10. Tatsumi, K., Kirkpatrick, B., Strauss, G. P., & Opler, M. (in press). The brief negative symptom scale in translation: A review of psychometric properties and beyond. European Neuropsychopharmacology

11. Cohen, A. S., Cowan, T. M., Le, T. P., Schwartz, E. K., Kirkpatrick, B., Raugh*, I. M., Chapman*, H. C., Strauss, G. P. (in press). Ambulatory digital phenotyping of blunted affect and alogia using objective facial and vocal analysis: Proof of concept. Schizophrenia Research.

12. Azis, M., Rouhakhatar, P.R., Schiffman, J.E., Ellman, L.M., Strauss, G.P., Mittal, V.A. (in press). The structure of positive psychotic symptoms in individuals at clinical high-risk for psychosis. Early Intervention in Psychiatry.

13. Cowan, H.R., Mittal, V.A., Allen, D.N., Gold, J.M., Strauss, G.P. (in press). Heterogeneity of emotional experience in schizophrenia: Trait positive and negative affect clusters predict clinical presentation and functional outcome. Journal of Abnormal Psychology.

14. Strauss, G.P., Pelletier-Baldelli, A., Visser*, K.F., Walker, E.F., Mittal, V.A. (in press). A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis. Schizophrenia Research.

15. Kafadar, E., Mittal, V.A., Strauss, G.P., Chapman*, H.C., Ellman, L.M., Bansal, S., Gold, J.M., Alderson-Day, B., Evans, S., Moffatt, J., Silverstein, S.M., Walker, E.F., Woods, S.W., Corlett, P.R., Powers, A.R. (in press). Modeling perception and behavior in individuals at clinical high-risk for psychosis: support for the predictive processing framework. Schizophrenia Research

16. Woods SW,Bearden CE, Sabb FW, Stone WS, Torous J, Cornblatt BA, Perkins DO, Cadenhead KS, Addington J, Powers III AR, Mathalon DH, Calkins ME, Wolf DH, Corcoran CM, Horton LE, Mittal VA, Schiffman JE, Ellman LE, Strauss GP, Mamah D, Choi J, Pearlson GD, Shah JL, Fusar-Poli P, Arango C, Perez J, Koutsouleris N, Wang J, Kwon JS, Walsh BC, McGlashan TH, Hyman SE, Gur RE, Cannon TD, Kane JM, Anticevic A. (in press). Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefit. Schizophrenia Research.

17.  Cohen, A. S., Schwartz, E. K., Le, T., Cowan, T. M., Kirkpatrick, B., Raugh*, I. M., Strauss, G.P. (in press). Digital phenotyping of negative symptoms: The relationship to clinician ratings. Schizophrenia Bulletin

18.  Gupta, T., Haase, C.M., Strauss, G.P., Cohen, A.S., Ricard, J.R., Mittal, V.A. (in press). Alterations in facial expressions of emotion: Determining the promise of ultra-thin slicing approaches and comparing human and automated coding methods in psychosis risk. Emotion.

19.  Bartolomeo*, L.A., Culbreth*, A.J., Ossenfort*, K.L., Strauss, G.P. (in press). Neurophysiological evidence for emotion regulation impairment in schizophrenia: the role of visual attention and cognitive effort. Journal of Abnormal Psychology


1. Raugh*, I.M., Chapman*, H.C., Bartolomeo*, L.A., Gonzalez*, C., & Strauss, G.P.​ (2019). A comprehensive review of psychophysiological applications for ecological momentary assessment in psychiatric populations. Psychological Assessment, 31, 304-317.

2. Cohen, A.S., Schwartz, E. K., Le, T., Fedechko, T., Kirkpatrick, B., Strauss, G.P. (2019). Using biobehavioral technologies to effectively advance research on negative symptoms. World Psychiatry, 18, 103-104.

3. Azis, M., Strauss, G.P., Walker, E.F., Revelle, W., Zinbarg, R., Mittal, V.A. (2019). Factor analysis of negative symptom items on the Structured Interview for Prodromal Syndromes. Schizophrenia Bulletin, 45, 1042-1050.


4.  Strauss, G.P., Ahmed, A.O., Young, J.A., Kirkpatrick, B. (2019). Reconsidering the latent structure of negative symptoms in schizophrenia: A review of evidence supporting the five consensus domains. Schizophrenia Bulletin, 45, 725-729.

5. Strauss, G.P., Esfahlani, F.Z., Kirkpatrick, B., Allen, D.N., Gold, J.M., Visser, K.F., Sayama, H. (2019). Network analysis reveals which negative symptom domains are most central in schizophrenia versus bipolar disorder. Schizophrenia Bulletin, 45, 1319-1330.

6. Yee, C., Strauss, G.P., Allen, D.N, Haase, C., Kimhy, D., & Mittal, V.A (2019). Trait emotional experience in individuals with schizophrenia and youth at clinical high-risk for psychosis. BJPsych Open, 5, e78.

7.   Chapman, H.C., Visser, K.H., Mittal, V.A., Gibb, B.E., Coles, M.E., Strauss, G.P. (2019). Emotion regulation across the psychosis continuum. Development & Psychopathology, 11, 1-9.

8. Gupta, T., Haase, C.M., Strauss, G.P., Cohen, A.S., Mittal, V.A. (2019). Alterations in facial expressivity in youth at clinical high-risk for psychosis. Journal of Abnormal Psychology, 128, 341-351.

9. Lee, M.R., Wehring, H.J., McMahon, R.P., Liu, F., Linthicum, J., Buchanan, R.W., Strauss, G.P., Rubin, L., Kelly, D.M. (2019). The effect of intranasal oxytocin on social cognition measures in schizophrenia: A negative report. Journal of Psychiatry and Brain Science, 4,(1)pii e190001.

10. Bartolomeo*, L.A., Erickson, M.A., Arnold*, L.E., Strauss, G.P. (2019). Frontal Alpha Asymmetry in Youth at Clinical High-Risk for Psychosis. Current Behavioral Neuroscience Reports, 6, 21-26.

11. Strauss, G.P., Chapman*, H.C., Keller, W.R., Koenig, J.I., Gold, J.M., Carpenter, W.T., Buchanan, R.W. (2019). Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia. Journal of Psychiatric Research, 112, 38-43.

12. Strauss, G.P., Granholm, E., Holden, J.L., Ruiz*, I., Gold, J.M., Kelly, D.L., Buchanan, R.W. (2019). The combined effects of oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia. Psychological Medicine, 49, 1731-1739.

13. Strauss, G.P., Zamani Esfahlani, F., Galderisi, S., Mucci, A., Rossi, A., Bertolino, A., Rocca, P., Maj, M., Kirkpatrick, B., Ruiz, I., Sayama, H. (2019). Network analysis reveals latent dimensions of negative symptoms in schizophrenia. Schizophrenia Bulletin, 45, 1033-1041.

14.  Strauss, G. P., Zamani Esfahlani, F.,  Visser, K. F., Dickinson, E. K., Gruber, J., & Sayama, H. (2019).  Mathematically Modeling Emotion Regulation Abnormalities During  Psychotic Experiences in Schizophrenia. Clinical Psychological Science, 7(2), 216-233.

15. Ahmed, A.O., Kirkpatrick, B., Galderisi, S., Mucci, A., Rossi, A., Bertolino, A., Rocca, P., Maj, M., Kaiser, S., Bischof, M., Hartmann-Riemer, M.N., Kirschner, M., Schneider, K., Garcia-Portilla, M.P., Mane, A., Bernardo, M., Fernandez-Egea, E., Jiefeng, C, Jing, Y, Shuping, T., Gold, J.M., Allen, D.N., Strauss, G.P. (2019). Cross-cultural validation of the five-factor model of negative symptoms in schizophrenia. Schizophrenia Bulletin, 45, 305-314.

16. Vargas, T., Ahmed, A., Strauss, G.P., Brandes, C.M., Walker, E., Gold, J., Buchanan, R., Mittal, V. (2019) The Latent Structure of Depressive Symptoms Across Clinical High Risk and Chronic Phases of Psychotic Illness. Translational Psychiatry, 9, 229. 

17. Chang, W.C., Chu, O.A., Treadway, M.T., Strauss, G.P., Chan, S.K., Lee, E.H., Hui, C.L., Suen, Y.N., Chen, E.Y. (2019) Effort-based decision-making impairment in patients with clinically-stabilized first-episode psychosis and its relationship with amotivation and psychosocial functioning. European Neuropsychophamracology, 29, 629-642.


1. Strauss, G.P., Chapman*, H.C. (2018). Preliminary Psychometric Properties of the Brief Negative Symptom Scale in Youth at Clinical High-Risk for Psychosis. Schizophrenia Research, 193, 435-437.

2. Strauss, G.P., Raugh*, I.M., Mittal, V.A., Gibb, B.E., Coles, M.E. (2018). Bullying victimization and perpetration in a community sample of youth with psychotic like experiences. Schizophrenia Research, 195, 534-536.

3. Gruber, J.M., Strauss, G.P., Dombrecht, L., Mittal, V.A. (2018). Neuroleptic-free youth at ultrahigh risk for psychosis evidence diminished emotion reactivity that is predicted by depression and anxiety. Schizophrenia Research, 193, 428-434.

4. Ahmed, A.O., Strauss, G.P., Buchanan, R.W., Kirkpatrick, B., Carpenter, W.T. (2018). Schizophrenia heterogeneity revisited: Clinical, cognitive, and psychosocial correlates of statistically-derived negative symptoms subgroups. Journal of Psychiatric Research, 97, 8-15.

5. Strauss, G.P., Cohen, A.S. (2018). The schizophrenia-spectrum anhedonia paradox. World Psychiatry, 17, 221-222.

6. Galderisi, S., Rucci, P., Kirkpatrick, B., Mucci, A., Gibertoni, D., Rocca, P., Rossi, A., Bertolino, A., Strauss, G.P., Aguglia, E., Bellomo, A., Belvederi Murri, M., Bucci, P., Carpiniello, B., Comparelli, A., Cuomo, A., De Berardis, D., Dell’Osso, L., Di Fabio, F., Gelao, B., Marchesi, C., Monteleone, P., Montemagni, C., Orsenigo, G., Pacitti, F., Roncone, R., Santonastaso, P., Siracusano, A, Vignapiano, A., Vita, A., Zeppegno, P., Maj, M. (2018). A network analysis of the interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia. JAMA Psychiatry, 75, 396-404.

7.  Li, Y., Li, W.X., Zou, Y.M., Yang, Z.Y., Xie, D.J., Yang, Y., Lui, S.S., Strauss, G.P., Cheung, E.F., Chan, R.C. (2018). Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms. Schizophrenia Research, 202, 248-253.

8. Strauss, G.P., Nunez, A., Ahmed, A.O., Barchard, K.A., Granholm, E., Kirkpatrick, B., Gold, J.M., Allen, D.N. (2018). The latent structure of negative symptoms in schizophrenia. JAMA Psychiatry, 75, 1271-1279.

9.  Vargas, T., Snyder, H., Newberry, R., Shankman, S.A., Strauss, G.P., Mittal. V.A., (2018). Altered selection during language processing in individuals at high risk for psychosis. Schizophrenia Research, 202, 303-309.

10. Yang, Y., Yang, Z.Y., Zou, Y.M., Shi,  H.S., Wang, Y., Xie, D.J., Zhang, R.T., Lui, S.S., Cohen, A.C., Strauss,  G.P. and Cheung, E.F., (2018). Low-pleasure beliefs in patients with  schizophrenia and individuals with social anhedonia. Schizophrenia research, 201, 137-144.

11. Goldsmith, D.R., Haroon, E., Miller, A.H., Strauss, G.P., Buckley, P.J., Miller, B.J. (2018). TNF and IL-6 are Associated with the Deficit Syndrome and Negative Symptoms in Patients with Chronic Schizophrenia. Schizophrenia Research, 199, 281-284.

12. Wehring, H.J., Buchanan, R.W., Feldman, S., Carpenter, W.T., McMahon, R.P., Weiner, E., Gold, J.M., Adams, H.A., Strauss, G.P., Rubin, L.H. and Kelly, D.L. (2018). Oxytocin and sexual function in males and females with schizophrenia. Schizophrenia Research, 199, 431-432.

13. Visser*, K.H., Zamani-Esfahlani*, F., Sayama, H., Strauss, G.P. (2018). An ecological momentary assessment evaluation of emotion regulation abnormalities in schizophrenia. Psychological Medicine, 48, 2337-2345.

14.  Ellenberg, S., Lynn, S. J., & Strauss, G. P. (2018). Psychotherapy for Schizophrenia‐Spectrum Disorders. Evidence‐Based Psychotherapy: The State of the Science and Practice, 363-405.

15.  Strauss, G. P., Ruiz, I., Dickinson,  E. K., & Visser, K. H. (2018). The Role of Negative Emotion  Abnormalities in Anhedonic Symptoms of Schizophrenia. In Neurobiology of Abnormal Emotion and Motivated Behaviors (pp. 258-276).

16.  Esfahlani, F. Z., Visser, K., Strauss,  G. P., & Sayama, H. (2018). A network-based classification  framework for predicting treatment response of schizophrenia patients. Expert Systems with Applications, 109, 152-161.

17.  Maxwell, R., Lynn, S. J., &  Strauss, G. P. (2018). Trait Emotion Regulation Predicts Individual  Differences in Momentary Emotion and Experience. Imagination, Cognition and Personality, 0276236618781775. 

18.  Stewart, E., Gibb, B.E., Strauss, G.P., & Coles, M.E. (2018). Disruptions in the amount and timing of sleep and repetitive negative thinking in adolescents. Behavioral Sleep Medicine, 1-9. 

19. Kirkpatrick, B., Saoud, J.B., Strauss, G.P., Ahmed, A.O., Tatsumi, K., Opler, M., Luthringer, R., Davidson, M. (2018). The Brief Negative Symptom Scale (BNSS): Sensitivity to Treatment Effects. Schizophrenia Research, 197, 279-273.

20. Strauss, G.P., Visser*, K.H., Keller, W.R., Gold, J.M., Buchanan, R.W. (2018). Anhedonia reflects impairment in making relative value judgments between positive and neutral stimuli in schizophrenia. Schizophrenia Research, 197, 156-161.


1. Cohen, A.S., Mitchell, K.R., Strauss, G.P., Blanchard, J.J., Buchanan, R.W., Kelly, D.L., Gold, J.M., McMahon, R.P., Adams, H. A., Carpenter, W.T. (2017). The effects of oxytocin and galantamine on objectively defined vocal and facial expressions: Data form the CIDAR study.  Schizophrenia Research, 188, 141-143. 

2. Sullivan*, S.K., Strauss, G.P. (2017). Electrophysiological evidence for detrimental impact of a reappraisal emotion regulation strategy on subsequent cognitive control in schizophrenia. Journal of Abnormal Psychology, 125(5), 679-693. 

3. Strauss, G.P., Cohen, A.S. (2017). A transdiagnostic review of negative symptom phenomenology and etiology. Schizophrenia Bulletin, 43 (4), 712-719. 

4. Strauss, G.P., Frost*, K.H., Lee*, B.G., Gold, J.M. (2017). The positivity offset theory of anhedonia in schizophrenia. Clinical Psychological Science, 5(2) 226-238. 

5. Buchanan, R.W., Kelly, D.L., Weiner, E., Gold, J.M., Strauss, G.P., Koola, M.M., McMahon, R.P., Carpenter, W.T. (2017). A Randomized Clinical Trial of Oxytocin and Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People with Schizophrenia. Journal of Clinical Psychopharmacology, 37(4), 394-400.  

6. Pellettier-Baldelli, A., Strauss, G.P., Visser*, K.H., Mittal, .A. (2017). Initial development and preliminary psychometric properties of the Prodromal Inventory of Negative Symptoms. Schizophrenia Research, 189, 43-49.     

7.  Strauss, G.P., Ruiz*, I., Visser*, K.H, Crespo*, L.P., Dickinson*, E.K. (in press). Diminished hedonic response in neuroleptic-free youth at ultra-high-risk for psychosis. Schizophrenia Research: Cognition.

8.  Esfahlani, F. Z., Sayama, H., Visser,  K. F., & Strauss, G. P. (2017). Sensitivity of the Positive And  Negative Syndrome Scale (PANSS) in detecting treatment effects via  network analysis. Innovations in clinical neuroscience, 14(11-12), 59.


1. Strauss, G.P., Gold, J.M. (2016). A psychometric comparison of the Clinical Assessment Interview for Negative Symptoms (CAINS) and the Brief Negative Symptom Scale (BNSS). Schizophrenia Bulletin, 42, 1384-1394.   

2. Bischof, M., Obermann, C., Hartmann, M.N., Hager, O.M., Kirschner, M., Kluge, A., Strauss, G.P., Kaiser, S. (2016). The Brief Negative Symptom Scale: Validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy. BMC Psychiatry, 16, 415.  

3. Strauss, G.P., Ossenfort*, K.L., Whearty*, K. M. (2016). Reappraisal and distraction emotion regulation strategies are associated with distinct patterns of visual attention. PlosOne, 11, e0162290.  

4. Frost*, K.H., Strauss, G.P. (2016). A review of anticipatory pleasure in schizophrenia. Current Behavioral Neuroscience Reports, 3, 232-247.

5. Lee, M.R ., Wehring, H.J., McMahon, R.P., Liu, F., Linthicum, J., Verbalis, J.G., Buchanan, R.W., Strauss, G.P., Rubin, L.H.,. Kelly, D.L (2016). Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia. Schizophrenia Research, 172, 165-168.  

6. Morra*, L.F., Strauss, G.P. (2016). The effects of hypertension on the generalized neurocognitive deficit in schizophrenia. Schizophrenia Research, 176, 527-528.  

7. Strauss, G.P., Whearty*, K.M., Morra*, L.F., Sullivan*, S.K., Ossenfort*, K.L., Frost*, K.H. (2016). Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a progressive ratio task. Schizophrenia Research, 170, 198-204.  

8. Strauss, G.P., Vertinski, M., Vogel, S.J., Ringdahl, E.N., Allen, D.N. (2016). Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the Brief Negative Symptom Scale across diagnostic categories. Schizophrenia Research, 170, 285-289.  

9. Cohen, A.S., Callaway, D.A., Mitchell, K.R., Larsen, J.T., Strauss, G.P. (2016). A temporal examination of co-activated valence networks in schizophrenia and schizotypy. Schizophrenia Research, 170, 322-329.  

10. Strauss, G.P., Frost*, K.H., Whearty, K.M., Carpenter, W.T. (2016). A translational affective neuroscience model of approach motivation in schizophrenia. Nebraska Symposium on Motivation, 63, 159-203.  

11. Carpenter, W.T., Whearty*, K.M., Frost*, K.H., Strauss, G.P. (2016). Avolition, negative symptoms, and a clinical science journey and transition to the future. Nebraska Symposium on Motivation, 63, 133-158.    


1. Strauss, G.P., Thaler, N.S., Matveeva, T.M., Vogel, S.J., Sutton, G.P., Lee, B.G., Allen, D.N. (2015). Predicting psychosis across diagnostic boundaries: Behavioral and computational modeling evidence for impaired reinforcement learning in schizophrenia and bipolar disorder with a history of psychosis. Journal of Abnormal Psychology, 124, 697-708.   

2. Whearty*, K.M., Allen, D.N., Lee, B.G., Strauss, G.P. (2015). The evaluation of insufficient cognitive effort in schizophrenia in light of low IQ scores. Journal of Psychiatric Research, 68, 397-404.  

3. Ahmed, A.A., Strauss, G.P., Buchanan, R.W., Kirkpatrick, B., Carpenter, W.T. (2015). Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia with Taxometric and Latent Variable Mixture Models. Schizophrenia Bulletin, 41, 879-891.  

4. Strauss, G.P., Kappenman, E.S., Culbreth, A.J., Catalano, L.T., Ossenfort*, K.L., Lee, B.G., Gold, J.M. (2015). Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli. Journal of Abnormal Psychology, 124, 288-301.

5. Morra*, L.F., Gold, J.M., Sullivan*, S.K. Strauss, G.P. (2015). Predictors of neuropsychological effort test performance in schizophrenia. Schizophrenia Research, 162, 205-210.  

6. Strauss, G.P., Morra*, L.F., Sullivan*, S.K., Gold, J.M. (2015). The role of low cognitive effort and negative symptoms in neuropsychological impairment in schizophrenia. Neuropsychology, 29, 282-291.  

7. Strauss, G.P., Keller, W.R., Koenig, J.I., Frost*, K.H., Gold, J.M., Buchanan, R.W. (2015). Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. Schizophrenia Research, 162, 47-51.  

8. Strauss, G.P., Keller, W.R., Koenig, J.I., Sullivan*, S.K., Gold, J.M., Buchanan, R.W. (2015). Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia. Schizophrenia Research, 162, 52-56.  

9. Strauss, G.P., Keller, W.R., Koenig, J.I., Gold, J.M., Ossenfort*, K.L., Buchanan, R.W. (2015). Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia. Schizophrenia Research, 162, 57-61.  

10. Coles, M.E., Strauss, G.P. (2015). Shedding light on tics. Psychiatry Research, 225, 743.  

11. Strauss, G. P., Culbreth, A. J.(2015). Assessing Psychosis in African American Clients. In Guide to Psychological Assessment with African Americans (pp. 247-259). Springer New York.    


1. Strauss, G.P., Waltz, J.A., Gold, J.M. (2014). A review of reward processing and motivational impairment in schizophrenia. Schizophrenia Bulletin, 40 (Suppl. 2), S107-116.  

2. Kiwanuka, J.N., Strauss, G.P., McMahon, R.P., Gold, J.M. (2014). Psychological predictors of functional outcome in people with schizophrenia. Schizophrenia Research, 157, 299-304.  

3. Keller, W.R., Vidal, C., Park E.S., Strauss, G.P., Fischer, B.F. (2014). The Risk of Diabetes in Deficit Schizophrenia. Clinical Schizophrenia & Related Psychoses, 7, 235-237.  

4. Strauss, G.P. (2014). Anhedonia in schizophrenia: A deficit in translating reward information into motivated behavior. In M.S. Ritsner (Eds.). Anhedonia: A Comprehensive Handbook Volume II. New York, NY: Springer, Publishing. s.   


1. Barney-Vogel, S.J., Strauss, G.P., Verbiest, R., Allen, D.N. (2013). Using negative feedback to guide behavior: Impairments on the first four cards of the Wisconsin Card Sorting Test predicts negative symptoms of schizophrenia. Schizophrenia Research, 151, 97-101.  

2. Brown, J.K., Waltz, J.A., Strauss, G.P., McMahon, R.P., Frank, M.J., Gold, J.M. (2013). Hypothetical decision making in schizophrenia: The role of expected value computation and “irrational” biases. Psychiatry Research, 209, 142-149.  

3. Strauss, G.P., & Allen, D.N. (2013). Emotional Verbal Learning Test: Psychometric Properties and Test Development. Archives of Clinical Neuropsychology, 28, 435-451.  

4. Strauss, G.P., Kappenman, E.S., Culbreth, A.J., Catalano, L.T., Lee, B.G., Gold, J.M. (2013). Emotion Regulation Abnormalities in Schizophrenia: Cognitive Change Strategies Fail to Decrease the Neural Response to Unpleasant Stimuli. Schizophrenia Bulletin, 39, 872-883.  

5. Strauss, G.P., Catalano, L.T., Llerena, K., Gold, J.M. (2013). The Processing of Emotional Stimuli during Periods of Limited Attentional Resources in Schizophrenia. Journal of Abnormal Psychology, 122, 492-505.  

6. Gold, J.M., Strauss, G.P., Waltz, J.A., Robinson, B.M., Brown, J.K., Frank, M.J. (2013). Negative Symptoms of Schizophrenia are Associated with Abnormal Effort-Cost Computations. Biological Psychiatry, 74, 130-136.  

7. Thaler, N.S., Allen, D.N., Sutton, G.P., Vertinski, M., Ringdahl, E.N., Strauss, G.P. (2013). Emotion perception abnormalities across sensory modalities in bipolar disorder with psychotic features and schizophrenia. Schizophrenia Research, 149, 287-292.  

8. Strauss, G.P. (2013). Translating basic emotion research into novel psychosocial interventions for anhedonia. Schizophrenia Bulletin, 39, 737-739.  

9. Strauss, G.P. (2013). The emotion paradox of anhedonia in schizophrenia: Or is it? Schizophrenia Bulletin, 39, 247-250.  

10. Strauss, G.P., Horan, W.P., Kirkpatrick, B, Fischer, B.A., Keller, W.R., Miski, P., Buchanan, R.W., Green, M.F., Carpenter, W.T. (2013). Deconstructing negative symptoms of schizophrenia: Avolition-apathy and emotional expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research, 47, 783-790.  

11. Allen, D.N., Strauss, G.P., Barchard, K. A., Vertinski, M., Carpenter, W.T., Buchanan, R.W. (2013). Differences in Developmental Changes in Academic and Social Premorbid Adjustment between Males and Females with Schizophrenia. Schizophrenia Research, 146, 132-137.  

12. Lee, M.R., Wehring, H.J., McMahon, R.P., Linthicum, J., Cascella, N., Liu, F., Bellack, A., Buchanan, R.W., Strauss, G.P., Contoreggi, C., Kelly, D.L. (2013). Adjunctive Intranasal Oxytocin in Schizophrenia Patients Improves Olfactory Identification and Negative Symptoms in a Context Dependent Manner: Results from a Double Blind Placebo Controlled Pilot Study. Schizophrenia Research, 145, 110-115.    


1. Strauss, G.P., Keller, W.R., Buchanan, R.W., Gold, J.M., Fischer, B.A., McMahon, R.P., Catalano, L.T., Culbreth, A.J., Carpenter, W.T., Kirkpatrick, B. (2012). Next-Generation Negative Symptom Assessment for Clinical Trials: Validation of the Brief Negative Symptom Scale. Schizophrenia Research, 142, 88-92.  

2. Strauss, G.P., Hong, L.E., Keller, W.R., Buchanan, R.W., Gold, J.M., Fischer, B.A., McMahon, R.P., Catalano, L.T., Culbreth, A.J., Carpenter, W.T., Kirkpatrick, B. (2012). Factor Structure of the Brief Negative Symptom Scale. Schizophrenia Research, 142, 96-98.  

3. Llerena, K., Strauss, G.P., Cohen, A.S. (2012). Looking at the other side of the coin: A meta-analysis of self-reported emotional arousal in individuals with schizophrenia. Schizophrenia Research, 142, 65-70.  

4. Strauss, G.P., Lee, B.G., Waltz, J.A., Robinson, B.M., Brown, J.K., Gold, J.M. (2012). Cognition-Emotion Interactions are Modulated by Working Memory Capacity in Individuals with Schizophrenia. Schizophrenia Research, 141, 257-261.  

5. Strauss, G.P., Sandt, A.R., Catalano, L.T., Allen, D.N. (2012). Negative symptoms and depression predict psychological well-being in individuals with schizophrenia. Comprehensive Psychiatry, 53, 1137-1144.  

6. Strauss, G.P., Gold, J.M., Cohen, A.S. (2012). Anticipatory and consummatory pleasure deficits across the schizophrenia spectrum. Psychiatry Research, 198, 174-175.  

7. Cohen, A.S., Callaway, D., Najolia, G.M., Larsen, J., Strauss, G.P. (2012). On “risk” and reward: state anhedonia in psychometrically-defined schizotypy but not schizophrenia. Journal of Abnormal Psychology, 121, 407-415.  

8. Gold, J.M., Waltz, J.A., Matveeva, T.M., Kasanova, Z, Strauss, G.P., Herbener, E.S., Collins, A.G.E., Frank, M.J. (2012). Negative symptoms in schizophrenia result from a failure to represent the expected value of rewards: Behavioral and computational modeling evidence. Archives of General Psychiatry, 69, 129-138.  

9. Strauss, G.P., & Gold, J.M. (2012). A New Perspective on Anhedonia in Schizophrenia. American Journal of Psychiatry, 169, 364-373.  

10. Strauss, G.P., Allen, D.N., Miski, P., Kirkpatrick, B., Buchanan, R.W., Carpenter, W.T. (2012). Differential patterns of premorbid academic and social deterioration in deficit and non-deficit schizophrenia. Schizophrenia Research, 135, 134-138.    


1. Strauss, G.P., Robinson, B.M., Waltz, J.A., Frank, M.J., Kasanova, Z., Herbener, E.S., Gold, J.M. (2011). Patients with Schizophrenia Demonstrate Inconsistent Preference Judgments for Affective and Non-Affective Stimuli. Schizophrenia Bulletin, 37, 1295-1304.  

2. Barney, S.J., Allen, D.N., Thaler, N.S., Park, B.S., Strauss, G.P., Mayfield, J. (2011). Neuropsychological and Behavioral Measures of Attention Assess Different Constructs in Children With Traumatic Brain Injury. The Clinical Neuropsychologist, 25, 1145-1157.  

3. Strauss, G.P., Llerena, K., Gold, J.M. (2011). Attentional Disengagement from Emotional Stimuli in Schizophrenia. Schizophrenia Research, 131, 219-223.  

4. Strauss, G.P., Herbener, E.S. (2011). Patterns of Emotional Experience in Schizophrenia: Differences in Emotional Response to Visual Stimuli are Associated with Clinical Presentation and Functional Outcome. Schizophrenia Research, 128, 117-123.  

5. Strauss, G.P., Wilbur, R.C., Warren, K.R., August, S.M., Gold, J.M. (2011). Anticipatory vs. Consummatory Pleasure: What is the Nature of Hedonic Deficits in Schizophrenia? Psychiatry Research, 187, 36-41.  

6. Kasanova, Z., Waltz, J.A., Strauss, G.P., Frank, M.J., Gold, J.M. (2011). Optimizing vs. Matching: Response strategy in a probabilistic learning task is associated with negative symptoms of schizophrenia. Schizophrenia Research, 127, 215-222.  

7. Strauss, G.P., Duke, L.A., Ross, S.A., Allen, D.N. (2011). Posttraumatic Stress Disorder and Negative Symptoms of Schizophrenia. Schizophrenia Bulletin, 37, 603-610.

8. Kirkpatrick, B., Strauss, G.P., Nguyen, L., Fischer, B.F., Daniel, D., Cienfuegos, A., Marder, S.R. (2011). The Brief Negative Symptom Scale: Psychometric Properties. Schizophrenia Bulletin, 37, 300-305.  

9. Strauss, G.P., Frank, M.F., Waltz, J.A., Kasanova, Z., Herbener, E.S., Gold, J.M. (2011). Deficits in Positive Reinforcement Learning and Uncertainty-Driven Exploration are Associated with Distinct Aspects of Negative Symptoms in Schizophrenia. Biological Psychiatry, 69, 424-431.    


1. Duke, L.A., Allen, D.N., Ross, S.A., Strauss, G.P. (2010). Neurocognitive Impairment in Schizophrenia with Comorbid PTSD. Journal of Clinical and Experimental Neuropsychology, 32, 737-751.  

2. Strauss, G.P., Allen, D.N., Ross, S.A., Duke, L.A., Schwartz, J. (2010). Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophrenia Bulletin, 36, 860-868.  

3. Strauss, G.P., Harrow, M., Grossman, L.S., Rosen, C. (2010). Periods of Recovery in Deficit Syndrome Schizophrenia: A 20-Year Multifollowup Longitudinal Study. Schizophrenia Bulletin, 36, 788-799.  

4. Strauss, G.P., Jetha, S.S., Duke, L.A., Ross, S.A., Allen, D.N. (2010) Impaired Facial Affect Labeling and Discrimination in Patients with Deficit Syndrome Schizophrenia. Schizophrenia Research, 118, 146-153.    


1. Gold, J.M., Hahn, B., Strauss, G.P., Waltz, J.A. (2009). Turning it Upside Down: Areas of Preserved Cognitive Function in Schizophrenia. Neuropsychology Review, 19 (3), 294-311.  

2. Strauss, G.P., Allen, D.N. (2009). Positive and negative emotions uniquely capture attention. Applied Neuropsychology, 16, 144-149.              


1. Grossman, L.S., Harrow, M., Rosen, C., Faull, R., Strauss, G.P. (2008). Sex Differences in Schizophrenia and Other Psychotic Disorders: A 20-Year Longitudinal Study of Psychosis and Recovery. Comprehensive Psychiatry, 49, 523-529.  

2. Strauss, G.P., Allen, D.N., Duke, L.A., Ross, S.A, Schwartz, J. (2008). Automatic affective processing impairments in patients with deficit syndrome schizophrenia. Schizophrenia Research, 102, 76-87.  

3. Lykins, A.D., Meana, M., & Strauss, G.P. (2008). Gender differences in visual attention to erotic stimuli. Archives of Sexual Behavior, 37, 219-228.  

4. Schwanenflugel, P.J., Morris, R.D., Kuhn, M.R., Strauss, G.P., Sieczko, J.M. (2008). The influence of reading unit size on the development of Stroop interference in early word decoding. Reading and Writing: An Interdisciplinary Journal, 21, 177-203.  

5. Strauss, G. P., & Allen, D. N. (2008). Emotional intensity and categorization ratings for emotional and nonemotional words. Cognition & Emotion, 22(1), 114-133.  

6. Allen D.N., Strauss G.P., Leany B.D., & Donohue B. (2008). Neuropsychological Assessment of Individuals with Substance Use Disorders. In A.M. Horton & D. Wedding (Eds.), The Neuropsychology Handbook, 3rd Edition. Springer Publishing Company: New York.                               


 1. Allen, D.N., Strauss, G.P., Kemtes, K.A., Goldstein, G. (2007). Hemispheric contributions to spatial problem solving. Neuropsychology, 21, 713-720.  

2. Allen, D.N., Strauss, G.P., Donohue, B., & van Kammen, D.P. (2007). Factor analytic support for social cognition as a separable cognitive domain in schizophrenia. Schizophrenia Research, 93, 325-333.      


1. Schwanenflugel, P.J., Meisinger, E., Wisenbaker, J.M., Kuhn, M.R., Strauss, G.P. & Morris, R.D. (2006). Becoming a fluent and automatic reader in the early elementary school years. Reading Research Quarterly, 41, 496-522.  

2. Strauss, G. P., & Allen, D. N. (2006). The experience of positive emotion is associated with the automatic processing of positive emotional words. Journal of Positive Psychology, 1 (3), 150-159.  

3. Allen, D.N., Forest, T.J., Frantom, L.V., & Strauss, G.P. (2006). Neuropsychology of Substance Use Disorders. In PJ Snyder & PD Nussbaum (Eds.), Clinical Neuropsychology Guidebook, 2nd Edition. Washington DC: American Psychological Association.      


1. Strauss, G. P., Allen, D. N., Jorgensen, M. L., & Cramer, S. L. (2005). Test-Retest reliability in Stroop and Emotional Stroop Tasks: An investigation of color-word and picture-word versions. Assessment, 12 (3), 330-337.  

2. Allen, D. N., Frantom, L.V., Strauss, G.P., & van Kammen, D.P. (2005). Differential patterns of premorbid academic and social deterioration in patients with schizophrenia. Schizophrenia Research, 75, 389-397.